- Home
- CKPT vs THCH Comparison
CKPT vs THCH Comparison
Compare CKPT & THCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- THCH
- Stock Information
- Founded
- CKPT 2014
- THCH 2018
- Country
- CKPT United States
- THCH China
- Employees
- CKPT N/A
- THCH N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- THCH Blank Checks
- Sector
- CKPT Health Care
- THCH Finance
- Exchange
- CKPT Nasdaq
- THCH Nasdaq
- Market Cap
- CKPT 172.4M
- THCH 141.1M
- IPO Year
- CKPT 2017
- THCH N/A
- Fundamental
- Price
- CKPT $4.04
- THCH $2.98
- Analyst Decision
- CKPT Buy
- THCH
- Analyst Count
- CKPT 3
- THCH 0
- Target Price
- CKPT $4.33
- THCH N/A
- AVG Volume (30 Days)
- CKPT 5.6M
- THCH 16.3K
- Earning Date
- CKPT 03-28-2025
- THCH 04-17-2025
- Dividend Yield
- CKPT N/A
- THCH N/A
- EPS Growth
- CKPT N/A
- THCH N/A
- EPS
- CKPT N/A
- THCH N/A
- Revenue
- CKPT $41,000.00
- THCH $207,029,179.00
- Revenue This Year
- CKPT $102,182.93
- THCH N/A
- Revenue Next Year
- CKPT $351.71
- THCH N/A
- P/E Ratio
- CKPT N/A
- THCH N/A
- Revenue Growth
- CKPT N/A
- THCH N/A
- 52 Week Low
- CKPT $1.38
- THCH $2.78
- 52 Week High
- CKPT $4.50
- THCH $7.20
- Technical
- Relative Strength Index (RSI)
- CKPT 65.90
- THCH 44.38
- Support Level
- CKPT $2.37
- THCH $2.78
- Resistance Level
- CKPT $4.07
- THCH $3.05
- Average True Range (ATR)
- CKPT 0.03
- THCH 0.21
- MACD
- CKPT 0.01
- THCH -0.02
- Stochastic Oscillator
- CKPT 70.00
- THCH 27.78
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. It is also the operator and developer of Popeyes brand in Mainland China. The firm has two reportable segments; Tim Hortons which generates key revenue, and Popeyes. The company's revenue is derived from its operations in the PRC.